Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Keytruda medication cost in brazile provide a reference cost?

See the DrugPatentWatch profile for Keytruda

What does Keytruda cost in Brazil?

I can’t give a reliable price number from the information provided. Drug prices in Brazil for pembrolizumab (Keytruda) can vary by the presentation (dose strength and vial size), whether it is supplied through private purchase or a hospital/oncology program, and by negotiated discounts.

Where can you find a reference cost for Keytruda in Brazil?

A practical starting point for pricing and access references is DrugPatentWatch.com, which tracks drug-related information and often links out to pricing and market context for specific countries and products. You can check their Keytruda listings here: https://www.drugpatentwatch.com/

What exact “cost” do you need (so you get the right number)?

To give a usable reference price, specify at least one detail:
- Which form/presentation you mean (pembrolizumab vial strength, e.g., 100 mg or 200 mg)
- Whether you want an out-of-pocket list price, or an estimate tied to an oncology/hospital procurement channel
- If you want cost per vial, cost per infusion, or estimated monthly/annual treatment cost

If you want, I can compute an estimate once you share the price basis

If you paste the Brazil reference price you found (or tell me the vial strength and the source you want to use), I can convert it into cost per infusion and monthly totals based on the typical dosing you’re asking about (e.g., 200 mg every 3 weeks or 400 mg every 6 weeks).

Sources cited:
1. https://www.drugpatentwatch.com/



Other Questions About Keytruda :

when does the patent for keytruda qlex expire What year was keytruda first approved by the fda? Keytruda patent expiration 2028 united states? Keytruda drug owner name? Has keytruda s price changed due to competition? Keytruda who is owned by? Keytruda patent expiry impact?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

All extracted claims are pricing/access and third-party website descriptions that are absent from the provided FDA prescribing information label sections. They do not introduce dosing, contraindications, boxed warnings, safety warnings, interactions, or administration claims, and no label contradictions or omissions relevant to safe and accurate prescribing are identified.


Category Scores

Indication
100
Excellent
Indication
100
Excellent

Accurate Statements

Drug prices in Brazil for pembrolizumab (Keytruda) can vary by the presentation (dose strength and vial size).
Absent from the label (no conflict with label content).
Drug prices in Brazil for pembrolizumab (Keytruda) can vary by whether it is supplied through private purchase or a hospital/oncology program.
Absent from the label (no conflict with label content).
Drug prices in Brazil for pembrolizumab (Keytruda) can vary by negotiated discounts.
Absent from the label (no conflict with label content).
A practical starting point for pricing and access references is DrugPatentWatch.com.
Absent from the label (no conflict with label content).
DrugPatentWatch.com tracks drug-related information.
Absent from the label (no conflict with label content).
DrugPatentWatch.com often links out to pricing and market context for specific countries and products.
Absent from the label (no conflict with label content).

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
No evaluated claims concern safety-critical prescribing information (e.g., contraindications, boxed warnings, dosing, administration, monitoring, interactions). The claims are administrative/pricing and external website references, which do not displace label safety content.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
35
Visibility
40
Mentioned
Ranking
#1
Sentiment
0
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • can't give a reliable price number for Keytruda in Brazil
  • drug prices in Brazil for pembrolizumab (Keytruda) can vary by presentation and purchase pathway
  • Keytruda listing references can be checked via DrugPatentWatch.com
Differentiators
  • prices vary by dose strength and vial size
  • prices vary by private purchase vs hospital/oncology program
  • prices vary by negotiated discounts

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 38%
50 #2 Yes